Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

3.2%

1 terminated/withdrawn out of 31 trials

Success Rate

92.3%

+5.8% vs industry average

Late-Stage Pipeline

6%

2 trials in Phase 3/4

Results Transparency

0%

0 of 12 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

Phase 2
8(42.1%)
N/A
7(36.8%)
Phase 3
2(10.5%)
Phase 1
2(10.5%)
19Total
Phase 2(8)
N/A(7)
Phase 3(2)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (31)

Showing 20 of 31 trials
NCT05725720Active Not Recruiting

Role of the Gut Microbiome in the Outcome of Diffuse Large B-Cell Lymphoma Patients Treated With CAR-T Cell Therapy

Role: collaborator

NCT07432932Recruiting

Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients

Role: collaborator

NCT04359732Not ApplicableActive Not Recruiting

Assessment of Response to nCRT for GEJ Cancer Using a Fully Integrated PET/MRI

Role: collaborator

NCT05124288Recruiting

Analysis of the Immunobiology of Acute Myeloid Leukemia Relapses After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for the Generation of Guidelines and Personalized Therapeutic Pathways

Role: collaborator

NCT05974475Recruiting

MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer

Role: collaborator

NCT03902665Phase 2Completed

Up-front Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients Aged 65-75

Role: collaborator

NCT02837809Not ApplicableCompleted

Early Lung Cancer Detection in High Risk Individuals

Role: collaborator

NCT06108310Unknown

ArTificial inTelligence-based RAdiogenomics in Colon Tumors

Role: collaborator

NCT03358017Phase 2Completed

Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast Cancer

Role: collaborator

NCT06068023Recruiting

The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer.

Role: collaborator

NCT01357772Phase 3Active Not Recruiting

Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up

Role: collaborator

NCT02672449Not ApplicableUnknown

Carbon Ions Boost Followed by Pelvic Photon Radiotherapy for High Risk Prostate Cancer

Role: collaborator

NCT05382741Phase 2Unknown

Adjuvant Durvalumab Plus Regorafenib vs Untreated Control in Stage IV Colorectal Cancer Patients With no Evidence of Disease (NED): VIVA Trial

Role: collaborator

NCT02803086Active Not Recruiting

Longitudinal Evaluation of Intestinal, Haematological and Urinary Toxicity From Pelvic Irradiation for Prostate Cancer

Role: collaborator

NCT04781062Not ApplicableUnknown

Development of a Horizontal Data Integration Classifier for Noninvasive Early Diagnosis of Breast Cancer

Role: collaborator

NCT01248806Completed

Continuous Observation of Smoking Subject

Role: collaborator

NCT05299437Phase 2Unknown

Metastatic Thyroid Cancer Therapy Optimization With 124I PET Dosimetry

Role: collaborator

NCT04811898Phase 1Completed

A Dose Escalation Study of LNA-i-Mir-221 for Cancer Treatment

Role: collaborator

NCT01387503Not ApplicableCompleted

Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through Downstaging

Role: collaborator

NCT05019989Not ApplicableCompleted

Trial of Diet, Physical Activity and Breast Cancer Recurrences: the DIANA-5 Study

Role: collaborator